Caxton Corp Marker Therapeutics, Inc. Transaction History

Caxton Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$4.1 - $9.0 $98,051 - $215,235	-23,915 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$5.15 - $7.92 $95,063 - $146,195	-18,459 Reduced 43.56%	23,915 $189,000
Q1 2019 May 14, 2019	SELL	$5.1 - $6.71 $55,870 - $73,508	-10,955 Reduced 20.54%	42,374 $280,000
Q4 2018 Feb 14, 2019	BUY	$4.2 - $9.74 $223,981 - $519,424	53,329 New	53,329 $296,000

475K

Ticker MRKR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,599,200
Market Cap $259M
Description
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...

Get notified when there are updates to the investment portfolio of Caxton Corp, based on Form 13F filings with the SEC.

Stay updated on Caxton Corp with notifications on news.